Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott E Millman

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Science Signaling|December 6, 2012
SCF-mediated degradation of p100 (NF-κB2): mechanisms and relevance in multiple myelomaLuca Busino, Scott E Millman, Michele Pagano
Blood|December 22, 2022
Metabolism in acute myeloid leukemia: mechanistic insights and therapeutic targetsSushanta Kumar Mishra, Scott E Millman, Lingbo Zhang
Blood|July 17, 2012
Fbw7γ-mediated degradation of KLF13 prevents RANTES expression in resting human but not murine T lymphocytesDong Seok Kim, Wei Zhang, Scott E Millman, et al.
Nature Cell Biology|March 6, 2012
Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myelomaLuca Busino, Scott E Millman, Luigi Scotto, et al.
Cancer Cell|January 15, 2020
Vitamin B6 Addiction in Acute Myeloid LeukemiaChi-Chao Chen, Bo Li, Scott E Millman, et al.
Nature|June 11, 2025
Metabolic adaptations direct cell fate during tissue regenerationAlmudena Chaves-Perez, Scott E Millman, Sudha Janaki-Raman, et al.
Blood|January 10, 2025
α-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemiaScott E Millman, Almudena Chaves-Perez, Sudha Janaki-Raman, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Science Signaling|December 6, 2012
SCF-mediated degradation of p100 (NF-κB2): mechanisms and relevance in multiple myelomaLuca Busino, Scott E Millman, Michele Pagano
Blood|December 22, 2022
Metabolism in acute myeloid leukemia: mechanistic insights and therapeutic targetsSushanta Kumar Mishra, Scott E Millman, Lingbo Zhang
Blood|July 17, 2012
Fbw7γ-mediated degradation of KLF13 prevents RANTES expression in resting human but not murine T lymphocytesDong Seok Kim, Wei Zhang, Scott E Millman, et al.
Nature Cell Biology|March 6, 2012
Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myelomaLuca Busino, Scott E Millman, Luigi Scotto, et al.
Cancer Cell|January 15, 2020
Vitamin B6 Addiction in Acute Myeloid LeukemiaChi-Chao Chen, Bo Li, Scott E Millman, et al.
Nature|June 11, 2025
Metabolic adaptations direct cell fate during tissue regenerationAlmudena Chaves-Perez, Scott E Millman, Sudha Janaki-Raman, et al.
Blood|January 10, 2025
α-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemiaScott E Millman, Almudena Chaves-Perez, Sudha Janaki-Raman, et al.
Pageof 1